Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to Prevent the Metabolic Complications of Olanzapine
NCT00682448Phase 4Completed
- Sponsor
- Rush University Medical Center
- Start
- Aug 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liquid metformin (Aspargo Labs) (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Weight Gain at 6 months. Started Aug 2007; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
Beyond the preview
Go deeper on NCT00682448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682448.